User:Mr. Ibrahem/Flumazenil
Clinical data | |
---|---|
Trade names | Anexate, Lanexat, Mazicon, Romazicon |
Other names | Flumazepil, Ro 15-1788, ethyl 8-fluoro- 5,6-dihydro- 5-methyl- 6-oxo- 4H- imidazo [1,5-a] [1,4] benzodiazepine- 3-carboxylate |
AHFS/Drugs.com | Monograph |
Pregnancy category |
|
Routes of administration | IV |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Metabolism | Liver |
Onset of action | Within 2 min[1] |
Elimination half-life | 7–15 min (initial) 20–30 min (brain) 40–80 min (terminal) |
Duration of action | 40 to 90 min[2] |
Excretion | Urine 90–95% Feces 5–10% |
Identifiers | |
| |
Chemical and physical data | |
Formula | C15H14FN3O3 |
Molar mass | 303.293 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Flumazenil, sold under the brand name Anexate, is a medication used to reverse the effects of benzodiazepines.[3] Routine use is not recommended in those with a decreased level of consciousness.[4] It is given by injection into a vein.[3] Effects begin within 2 minutes and may last for up to 90 minutes.[1][2]
Common side effects include sweating, blurry vision, headache, and dizziness.[1] Other side effects may include seizures and benzodiazepine withdrawal, especially in people with benzodiazepine dependence.[1] Panic attacks may also occur.[1] Safety in pregnancy is unclear.[5] It works by blocking benzodiazepines at the GABA receptor.[1]
Flumazenil was characterized in 1981, and approved for medical use in the United States in 1991.[6][1] It is available as a generic medication.[3] In the United Kingdom 0.5 mg cost the NHS about £13 as of 2021.[3] This amount in the United States is about 10 USD.[7]
References[edit]
- ^ a b c d e f g h "Flumazenil Monograph for Professionals". Drugs.com. Archived from the original on 30 September 2020. Retrieved 11 December 2021.
- ^ a b c Wilson, William C.; Grande, Christopher M.; Hoyt, David B. (5 February 2007). Trauma: Critical Care. CRC Press. p. 85. ISBN 978-1-4200-1684-0. Archived from the original on 11 December 2021. Retrieved 11 December 2021.
- ^ a b c d e BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 1422. ISBN 978-0857114105.
- ^ Wood, Lawrence D. H.; Hall, Jesse B.; Schmidt, Gregory D. 1952 (2005). Principles of critical care. McGraw-Hill Professional. ISBN 978-0-07-141640-5. Archived from the original on 2020-12-16. Retrieved 2021-06-07.
{{cite book}}
: CS1 maint: numeric names: authors list (link) - ^ "Flumazenil (Romazicon) Use During Pregnancy". Drugs.com. Archived from the original on 3 December 2020. Retrieved 11 December 2021.
- ^ Whitwam, James. G. (1988). "Flumazenil: a benzodiazepine antagonist". BMJ. 297 (6655): 999–1000. doi:10.1136/bmj.297.6655.999. PMC 1834756. PMID 2903780.
- ^ "Flumazenil Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 22 January 2021. Retrieved 11 December 2021.